IDEC-114

DRUG2 trials

Sponsors

Biogen

Conditions

Non-Hodgkin's Lymphoma

Phase 1

Safety and Efficacy of IDEC-114 in Combination With Rituxan in the Treatment of Non-Hodgkin's Lymphoma

CompletedNCT00048555

BiogenNon-Hodgkin's Lymphoma

Start: 2002-11-30End: 2010-11-30Updated: 2013-09-16

Safety and Efficacy of IDEC-114 in the Treatment of Non-Hodgkin's Lymphoma

CompletedNCT00575068

BiogenNon-Hodgkin's Lymphoma

Start: 2002-01-31End: 2010-11-30Updated: 2012-06-08